ISHARES TR - GENOMICS IMMUN (IDNA)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / GENOMICS IMMUN
Total 13F shares
1,618,890
Share change
-227,198
Total reported value
$32,867,922
Price per share
$20.35
Number of holders
62
Value change
-$4,993,482
Number of buys
24
Number of sells
29

Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q3 2023

As of 30 Sep 2023 ISHARES TR - GENOMICS IMMUN (IDNA) had 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,618,890 shares of stock of the company.
Largest 10 holders included Wharton Business Group, LLC, JANE STREET GROUP, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, AMERIPRISE FINANCIAL INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Royal Bank of Canada, Integrated Wealth Concepts LLC, LPL Financial LLC, and COMMONWEALTH EQUITY SERVICES, LLC.
This table shows 63 institutional shareholders of the security as of 30 Sep 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.